Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases Review

Zhao, Yingying, Kuca, Kamil, Wu, Wenda et al. (2022). Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases . Alzheimer's and Dementia, 18(1), 152-158. 10.1002/alz.12370

International Collaboration

cited authors

  • Zhao, Yingying; Kuca, Kamil; Wu, Wenda; Wang, Xu; Nepovimova, Eugenie; Musilek, Kamil; Wu, Qinghua

sustainable development goals

authors

publication date

  • January 1, 2022

published in

keywords

  • ALZHEIMERS-DISEASE
  • APOPTOSIS
  • Alzheimer&apos
  • C-JUN
  • Clinical Neurology
  • IMPAIRMENT
  • INDUCTION
  • JNK
  • Life Sciences & Biomedicine
  • MOUSE MODEL
  • N-TERMINAL KINASE
  • Neurosciences & Neurology
  • PHOSPHORYLATION
  • PROTECTS DOPAMINERGIC-NEURONS
  • Science & Technology
  • TAU
  • amyloid beta
  • neurodegenerative diseases
  • s disease
  • tau

Digital Object Identifier (DOI)

start page

  • 152

end page

  • 158

volume

  • 18

issue

  • 1